Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
Abstract Background Tumor necrosis factor inhibitors (TNFi) have emerged as an efficient therapeutic modality for rheumatoid arthritis (RA). A ratio of patients does not give a response despite therapy. It remains a challenge to predict which patients will respond. Our study aims to investigate earl...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SpringerOpen
2024-05-01
|
| Schriftenreihe: | Egyptian Rheumatology and Rehabilitation |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s43166-024-00260-x |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
